Waterless alternative to laboratory baths

Published: 27-Jul-2010
Manufacturing

Bead Bath delivers temperature uniformity while eliminating water

Lab Armor, a US manufacturer of laboratory products, has introduced a waterless alternative to contamination-prone traditional laboratory water baths.

The San Antonio, Texas-based firm says the waterless Bead Bath delivers exceptional temperature uniformity while eliminating water, which can be a major source of contamination in laboratories.

The Bead Bath is always on, ready for the next experiment, so scientists do not have to plan around warm-up times. There is also no risk of burn out because there is no water to evaporate. The Bead Bath also keeps samples organised, naturally holding vessels in place without the need for racks, floats and bottleneck weights.

In addition to watertight containers, scientists can safely incubate multi-well plates, petri dishes, and open-top samples at any angle.

The Bead Bath also requires little maintenance.

Lab Armor Beads can be used to replace water in existing water baths, aluminum blocks in dry baths and even ice in ice buckets. These beads can also be used in containers placed in ovens and incubators to replace sample racks.

The Lab Armor Bead Bath’s thermal uniformity is: 37°C ±0.5°C and 65°C ±1.0°C with a temperature range of 5°C above ambient to 80°C. They support a temperature range of –100°C to +400°C in laboratory equipment.

See more

You may also like

Manufacturing

Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

Read more
By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence

Trending Articles

  1. Compact, economical and sustainable cooling solutions for laboratories Huber Unichillers offer space-saving and environmentally friendly temperature control for research and industrial applications
  2. Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
  3. Bruker announces major strides in 4D proteomics performance, further advances In intact and top-down functional proteoform analysis, and innovations in hybrid qual/quant 4D metabolomics All to enable deeper insights into disease biology. Bruker Also Launches Two Novel Mass Spectrometry Systems for Unique Applications in Energy Industry Research, and in Semiconductor Manufacturing
  4. CEPI fast-tracks three Bundibugyo ebolavirus vaccine candidates amid DRC outbreak With no licensed vaccines available and more than 900 suspected cases already recorded, CEPI is urgently advancing mRNA, rVSV and viral vector candidates from Moderna, IAVI and Oxford/SII toward clinical trials
  5. FDA Form 483 flags falsified records and live bird infestation at Dabur India OTC plant A FDA inspection report issued in January 2026 has revealed widespread CGMP failures at Dabur India's Dadra and Nagar Haveli facility, including manipulated microbiology data, fraudulent equipment logs and unsanitary storage conditions

Upcoming event

BIO International Convention

22–25 June 2026 | Convention | Boston, US See all

You may also like

Manufacturing

Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing

Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration

CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
Manufacturing

Cutting-edge wiped film evaporator installation – non-tobacco nicotine products

Successful system installation for a UK research and development facility developing and commercialising non-tobacco nicotine products using industry-leading evaporation equipment
Manufacturing

Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe

After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity to meet European market demand for pharmaceutical ampoules. Facility brings around 180 new jobs to the region
Manufacturing

Why integrated outsourcing wins in modern drug development

Aligning drug substance and drug product development within a single outsourcing model accelerates timelines, sharpens CMC decisions and reduces risk by enabling parallel workstreams and shared governance
Manufacturing

Bruker announces major strides in 4D proteomics performance, further advances In intact and top-down functional proteoform analysis, and innovations in hybrid qual/quant 4D metabolomics

All to enable deeper insights into disease biology. Bruker Also Launches Two Novel Mass Spectrometry Systems for Unique Applications in Energy Industry Research, and in Semiconductor Manufacturing
Manufacturing

ystral opens ATEX-compliant trial centre in Germany to expand customer process development capacity

The new facility, based in Ballrechten-Dottingen, will be able to handle flammable and explosive media testing across pharma, coatings and food applications, with remote livestream access and in-house particle size and viscosity analysis
Subscribe now